<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03545919</url>
  </required_header>
  <id_info>
    <org_study_id>2018-20-K15</org_study_id>
    <nct_id>NCT03545919</nct_id>
  </id_info>
  <brief_title>Clinical Significance of Community-acquired Respiratory Virus Infection and Longitudinal Analysis of the Lung Microbiome in Lung Transplantation</brief_title>
  <official_title>Clinical Significance of Community-acquired Respiratory Virus Infection and Longitudinal Analysis of the Lung Microbiome in Lung Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Capital Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>China-Japan Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chinese Academy of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Capital Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the clinical significance of community-acquired
      respiratory virus (CARV) infection in patients with lung transplantation;Explore the lung
      microbiome dynamics within one year after lung transplantation;Find the relationship between
      lung microbiome and chronic lung allograft dysfunction(CLAD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Title:Clinical Significance of Community-acquired Respiratory Virus Infection and
      Longitudinal Analysis of the Lung Microbiome in Lung Transplantation.

      Background:Infection affects the short-term prognosis of patients with lung transplantation
      and chronic lung allograft dysfunction(CLAD) limits their long-term survival.It is important
      to provide more theoretical support for early diagnosis and treatment of acute respiratory
      tract infection and CLAD in patients with lung transplantation.

      Study Objectives:Evaluate the clinical significance of community-acquired respiratory virus
      (CARV) infection in patients with lung transplantation;Explore the lung microbiome dynamics
      within one year after lung transplantation;Find the relationship between lung microbiome and
      CLAD.

      Study Design:A prospective and longitudinal study,following up the patients for 3 years.

      Sample Size:100 cases. Study methods:CARV detection for respiratory specimens are performed
      during acute infection and routine re-testing in patients after lung
      transplantation,following up the patients who have positive findings to analyze the
      progression rates to lower respiratory tract infection,mortality rate within 90 days and risk
      factors associated with progression and death.For HRV/CoVs/HBoV detecting positive patients,
      consecutively collect respiratory specimens to quantitate viral load and combine virus
      serology to further confirm their pathogenicity on host.Complete a longitudinal 16S ribosomal
      RNA and metagenomics survey of the lung microbiome on respiratory samples collected from
      routine testing or re-testing（pre-operation,24 hours after the operation，day 3, day 7, week
      2, week 3, month 1, month 3, month 6, month 9, month 12 , month 18, month 24, month 30, month
      36) to explore the lung microbiome dynamics within one year after lung transplantation and
      find the relationship between lung microbiome and CLAD after 3 years
      follow-up.Besides,collect the peripheral blood of some patients for transcriptome and/or
      whole genome sequencing to screen for the host susceptibility genes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">August 5, 2018</start_date>
  <completion_date type="Anticipated">June 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The progression rates from upper respiratory tract infection to lower respiratory tract infection within 40 days after diagnosis.</measure>
    <time_frame>40 days after diagnosis</time_frame>
    <description>CARV detection for respiratory specimens are performed during acute infection and routine re-testing in patients after lung transplantation,following up the patients who have positive findings to analyze the progression rates to lower respiratory tract infection.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mortality rate within 90 days after diagnosis of respiratory viral infections</measure>
    <time_frame>90 days after diagnosis of respiratory viral infections</time_frame>
    <description>CARV detection for respiratory specimens are performed during acute infection and routine re-testing in patients after lung transplantation,following up the patients who have positive findings to analyze mortality rate within 90 days after diagnosis of respiratory viral infections</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Explore the lung microbiome dynamics within one year after lung transplantation.</measure>
    <time_frame>1 year follow-up after lung transplantation</time_frame>
    <description>Complete a longitudinal 16S ribosomal RNA and metagenomics survey of the lung microbiome on respiratory samples collected from routine testing or re-testing（pre-operation,24 hours after the operation，day 3, day 7, week 2, week 3, month 1, month 3, month 6, month 9, month 12)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Whether chronic lung allograft dysfunction occurs for individuals after 3 years follow-up after lung transplantation and find the relationship between lung microbiome and CLAD</measure>
    <time_frame>3 years follow-up after lung transplantation</time_frame>
    <description>Complete a longitudinal 16S ribosomal RNA and metagenomics survey of the lung microbiome on respiratory samples collected from routine testing or re-testing（24 hours after the operation，month 3, month 6, month 9, month 12 , month 18, month 24, month 30, month 36)</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Lung Transplant Infection</condition>
  <condition>Lung Transplant Rejection</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood Bronchoalveolar lavage fluid
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        100 patients with lung transplantation who meet the below inclusion criteria will be
        recruited in China-Japan Friendship Hospital in Beijing,China.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1.Patients with lung transplantation. 2.The patients who agree to participate in this
             study and sign informed consent.

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Si si Du, Ph.D</last_name>
    <phone>86 13512916908</phone>
    <email>dusisi511@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bin Cao, MD</last_name>
    <phone>86-010-84206264</phone>
    <email>caobin_ben@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>China-Japan Friendship Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100029</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bin Cao, MD</last_name>
      <phone>86-010-84206264</phone>
      <email>caobin_ben@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Si si Du, Ph.D</last_name>
      <phone>86 13512916908</phone>
      <email>dusisi511@126.com</email>
    </contact_backup>
    <investigator>
      <last_name>Bin Cao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wen hui Chen, Attending Physician</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Chambers DC, Yusen RD, Cherikh WS, Goldfarb SB, Kucheryavaya AY, Khusch K, Levvey BJ, Lund LH, Meiser B, Rossano JW, Stehlik J; International Society for Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung And Heart-Lung Transplantation Report-2017; Focus Theme: Allograft ischemic time. J Heart Lung Transplant. 2017 Oct;36(10):1047-1059. doi: 10.1016/j.healun.2017.07.016. Epub 2017 Jul 19. Review.</citation>
    <PMID>28784324</PMID>
  </results_reference>
  <results_reference>
    <citation>Peghin M, Hirsch HH, Len Ó, Codina G, Berastegui C, Sáez B, Solé J, Cabral E, Solé A, Zurbano F, López-Medrano F, Román A, Gavaldá J. Epidemiology and Immediate Indirect Effects of Respiratory Viruses in Lung Transplant Recipients: A 5-Year Prospective Study. Am J Transplant. 2017 May;17(5):1304-1312. doi: 10.1111/ajt.14042. Epub 2016 Oct 14.</citation>
    <PMID>27615811</PMID>
  </results_reference>
  <results_reference>
    <citation>Bridevaux PO, Aubert JD, Soccal PM, Mazza-Stalder J, Berutto C, Rochat T, Turin L, Van Belle S, Nicod L, Meylan P, Wagner G, Kaiser L. Incidence and outcomes of respiratory viral infections in lung transplant recipients: a prospective study. Thorax. 2014 Jan;69(1):32-8. doi: 10.1136/thoraxjnl-2013-203581. Epub 2013 Sep 11.</citation>
    <PMID>24025442</PMID>
  </results_reference>
  <results_reference>
    <citation>Seo S, Gooley TA, Kuypers JM, Stednick Z, Jerome KR, Englund JA, Boeckh M. Human Metapneumovirus Infections Following Hematopoietic Cell Transplantation: Factors Associated With Disease Progression. Clin Infect Dis. 2016 Jul 15;63(2):178-85. doi: 10.1093/cid/ciw284. Epub 2016 May 3.</citation>
    <PMID>27143659</PMID>
  </results_reference>
  <results_reference>
    <citation>Bernasconi E, Pattaroni C, Koutsokera A, Pison C, Kessler R, Benden C, Soccal PM, Magnan A, Aubert JD, Marsland BJ, Nicod LP; SysCLAD Consortium. Airway Microbiota Determines Innate Cell Inflammatory or Tissue Remodeling Profiles in Lung Transplantation. Am J Respir Crit Care Med. 2016 Nov 15;194(10):1252-1263.</citation>
    <PMID>27248293</PMID>
  </results_reference>
  <results_reference>
    <citation>Mouraux S, Bernasconi E, Pattaroni C, Koutsokera A, Aubert JD, Claustre J, Pison C, Royer PJ, Magnan A, Kessler R, Benden C, Soccal PM, Marsland BJ, Nicod LP; SysCLAD Consortium. Airway microbiota signals anabolic and catabolic remodeling in the transplanted lung. J Allergy Clin Immunol. 2018 Feb;141(2):718-729.e7. doi: 10.1016/j.jaci.2017.06.022. Epub 2017 Jul 18.</citation>
    <PMID>28729000</PMID>
  </results_reference>
  <results_reference>
    <citation>Willner DL, Hugenholtz P, Yerkovich ST, Tan ME, Daly JN, Lachner N, Hopkins PM, Chambers DC. Reestablishment of recipient-associated microbiota in the lung allograft is linked to reduced risk of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med. 2013 Mar 15;187(6):640-7. doi: 10.1164/rccm.201209-1680OC. Epub 2013 Jan 17.</citation>
    <PMID>23328523</PMID>
  </results_reference>
  <results_reference>
    <citation>Borewicz K, Pragman AA, Kim HB, Hertz M, Wendt C, Isaacson RE. Longitudinal analysis of the lung microbiome in lung transplantation. FEMS Microbiol Lett. 2013 Feb;339(1):57-65. doi: 10.1111/1574-6968.12053. Epub 2012 Dec 20.</citation>
    <PMID>23173619</PMID>
  </results_reference>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>May 13, 2018</study_first_submitted>
  <study_first_submitted_qc>May 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2018</study_first_posted>
  <last_update_submitted>August 5, 2018</last_update_submitted>
  <last_update_submitted_qc>August 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Capital Medical University</investigator_affiliation>
    <investigator_full_name>Bin Cao</investigator_full_name>
    <investigator_title>Doctor of Medicine</investigator_title>
  </responsible_party>
  <keyword>respiratory viral infections</keyword>
  <keyword>chronic lung allograft dysfunction</keyword>
  <keyword>lung microbiome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Virus Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

